Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | trypanothione reductase | 0.0071 | 0.0224 | 0.0428 |
Echinococcus granulosus | fructose 16 bisphosphate aldolase | 0.062 | 0.3196 | 0.8786 |
Brugia malayi | Phosphatidylinositol-specific phospholipase C, X domain containing protein | 0.0049 | 0.0106 | 0.0106 |
Echinococcus granulosus | fructose bisphosphate aldolase class I | 0.062 | 0.3196 | 0.8786 |
Echinococcus granulosus | fructose 16 bisphosphate aldolase | 0.062 | 0.3196 | 0.8786 |
Trypanosoma brucei | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0097 | 0.0363 | 0.0615 |
Loa Loa (eye worm) | phosphatidylinositol-specific phospholipase C | 0.0049 | 0.0106 | 0.0022 |
Entamoeba histolytica | MIR domain protein | 0.0152 | 0.0664 | 0.5 |
Onchocerca volvulus | 0.0149 | 0.0645 | 0.9143 | |
Brugia malayi | MIR domain containing protein | 0.0152 | 0.0664 | 0.0664 |
Schistosoma mansoni | phospholipase C-like protein 2 plc-L2 | 0.0082 | 0.0281 | 0.0069 |
Brugia malayi | Ryanodine Receptor TM 4-6 family protein | 0.0972 | 0.5107 | 0.5107 |
Leishmania major | phospholipase c-like protein | 0.0049 | 0.0106 | 0.0049 |
Onchocerca volvulus | 0.0152 | 0.0664 | 1 | |
Loa Loa (eye worm) | glutathione reductase | 0.0071 | 0.0224 | 0.019 |
Schistosoma mansoni | phospholipase C beta | 0.0109 | 0.0427 | 0.0246 |
Loa Loa (eye worm) | hypothetical protein | 0.1336 | 0.7077 | 1 |
Toxoplasma gondii | fructose-1,6-bisphosphate aldolase | 0.062 | 0.3196 | 1 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.0695 | 0.3606 | 1 |
Leishmania major | fructose-1,6-bisphosphate aldolase | 0.062 | 0.3196 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0071 | 0.0224 | 0.019 |
Schistosoma mansoni | ryanodine receptor related | 0.0972 | 0.5107 | 0.5901 |
Schistosoma mansoni | fructose 16-bisphosphate aldolase | 0.062 | 0.3196 | 0.3591 |
Echinococcus granulosus | 1-Phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-4 | 0.0111 | 0.0442 | 0.0646 |
Echinococcus multilocularis | fructose 1,6 bisphosphate aldolase | 0.062 | 0.3196 | 0.8786 |
Plasmodium falciparum | fructose-bisphosphate aldolase | 0.062 | 0.3196 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1318 | 0.698 | 0.9861 |
Trypanosoma brucei | inositol 1,4,5-trisphosphate receptor | 0.082 | 0.4282 | 1 |
Trypanosoma cruzi | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0092 | 0.034 | 0.0559 |
Brugia malayi | phospholipase C homolog | 0.0082 | 0.0281 | 0.0281 |
Loa Loa (eye worm) | hypothetical protein | 0.0092 | 0.034 | 0.0356 |
Echinococcus multilocularis | 1 phosphatidylinositol 4,5 bisphosphate | 0.0111 | 0.0442 | 0.0646 |
Loa Loa (eye worm) | hypothetical protein | 0.0092 | 0.034 | 0.0356 |
Loa Loa (eye worm) | Plcb4 protein | 0.0109 | 0.0427 | 0.0481 |
Leishmania major | hypothetical protein, conserved | 0.0557 | 0.2859 | 0.8916 |
Toxoplasma gondii | fructose-bisphosphate aldolase, putative | 0.062 | 0.3196 | 1 |
Schistosoma mansoni | fructose 16-bisphosphate aldolase | 0.062 | 0.3196 | 0.3591 |
Loa Loa (eye worm) | ryanodine receptor | 0.0263 | 0.1261 | 0.1675 |
Brugia malayi | glutathione reductase | 0.0071 | 0.0224 | 0.0224 |
Brugia malayi | fructose-bisphosphate aldolase 2 | 0.062 | 0.3196 | 0.3196 |
Schistosoma mansoni | stromal cell-derived factor 2 precursor-like protein | 0.0152 | 0.0664 | 0.0532 |
Echinococcus multilocularis | fructose 1,6 bisphosphate aldolase | 0.062 | 0.3196 | 0.8786 |
Brugia malayi | Thioredoxin reductase | 0.0071 | 0.0224 | 0.0224 |
Toxoplasma gondii | thioredoxin reductase | 0.0071 | 0.0224 | 0.0381 |
Echinococcus granulosus | cytohesin 1 | 0.0102 | 0.0393 | 0.05 |
Echinococcus granulosus | stromal cell derived factor 2 | 0.0152 | 0.0664 | 0.1302 |
Brugia malayi | 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta 4 | 0.0109 | 0.0427 | 0.0427 |
Echinococcus multilocularis | fructose 1,6 bisphosphate aldolase | 0.062 | 0.3196 | 0.8786 |
Plasmodium vivax | glutathione reductase, putative | 0.0071 | 0.0224 | 0.0428 |
Echinococcus multilocularis | fructose bisphosphate aldolase class I | 0.062 | 0.3196 | 0.8786 |
Loa Loa (eye worm) | fructose-bisphosphate aldolase 1 | 0.062 | 0.3196 | 0.4445 |
Echinococcus granulosus | ryanodine receptor 44f | 0.0695 | 0.3606 | 1 |
Schistosoma mansoni | ryanodine receptor 1 skeletal muscle | 0.0263 | 0.1261 | 0.1254 |
Echinococcus granulosus | fructose 16 bisphosphate aldolase | 0.062 | 0.3196 | 0.8786 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.062 | 0.3196 | 0.7399 |
Loa Loa (eye worm) | hypothetical protein | 0.118 | 0.6233 | 0.8792 |
Leishmania major | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0092 | 0.034 | 0.0801 |
Echinococcus multilocularis | cytohesin 1 | 0.0102 | 0.0393 | 0.05 |
Brugia malayi | Cytohesin 3 | 0.0102 | 0.0393 | 0.0393 |
Echinococcus multilocularis | stromal cell derived factor 2 | 0.0152 | 0.0664 | 0.1302 |
Plasmodium vivax | fructose 1,6-bisphosphate aldolase, putative | 0.062 | 0.3196 | 1 |
Trypanosoma cruzi | inositol 1,4,5-trisphosphate receptor, putative | 0.082 | 0.4282 | 1 |
Brugia malayi | Phosphatidylinositol-specific phospholipase C, X domain containing protein | 0.0047 | 0.0091 | 0.0091 |
Loa Loa (eye worm) | variant SH3 domain-containing protein | 0.0052 | 0.0123 | 0.0046 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.062 | 0.3196 | 0.7399 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.118 | 0.6233 | 0.7261 |
Trichomonas vaginalis | mannosyltransferase 1, putative | 0.0152 | 0.0664 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0695 | 0.3606 | 0.5032 |
Schistosoma mansoni | guanyl-nucleotide exchange factor | 0.0102 | 0.0393 | 0.0204 |
Trypanosoma brucei | fructose-bisphosphate aldolase, glycosomal, putative | 0.062 | 0.3196 | 0.7399 |
Loa Loa (eye worm) | hypothetical protein | 0.026 | 0.1249 | 0.1657 |
Brugia malayi | Variant SH3 domain containing protein | 0.0052 | 0.0123 | 0.0123 |
Trypanosoma cruzi | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0092 | 0.034 | 0.0559 |
Loa Loa (eye worm) | hypothetical protein | 0.0092 | 0.034 | 0.0356 |
Schistosoma mansoni | phospholipase C-like protein 2 plc-L2 | 0.0179 | 0.0806 | 0.0704 |
Plasmodium falciparum | glutathione reductase | 0.0071 | 0.0224 | 0.0428 |
Plasmodium falciparum | thioredoxin reductase | 0.0071 | 0.0224 | 0.0428 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.0442 | 0.0503 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.062 | 0.3196 | 0.7399 |
Loa Loa (eye worm) | hypothetical protein | 0.0149 | 0.0645 | 0.0793 |
Toxoplasma gondii | fructose-1,6-bisphosphate aldolase | 0.062 | 0.3196 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0071 | 0.0224 | 0.0428 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.1598 | 0.8499 | 1 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.062 | 0.3196 | 0.7399 |
Trypanosoma brucei | trypanothione reductase | 0.0071 | 0.0224 | 0.0282 |
Loa Loa (eye worm) | MIR domain-containing protein | 0.0152 | 0.0664 | 0.0821 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.054 | 0.2762 | 0.7505 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0071 | 0.0224 | 0.0282 |
Loa Loa (eye worm) | cytohesin 3 | 0.0102 | 0.0393 | 0.0432 |
Brugia malayi | fructose-bisphosphate aldolase 1 | 0.062 | 0.3196 | 0.3196 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0071 | 0.0224 | 0.5 |
Echinococcus granulosus | ryanodine receptor 44f | 0.054 | 0.2762 | 0.7505 |
Loa Loa (eye worm) | fructose-bisphosphate aldolase 2 | 0.062 | 0.3196 | 0.4445 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ratio (functional) | = 0 | Compound was evaluated for affinity ratio of dopamine D2 receptor to dopamine D3 receptor; 1:10 | ChEMBL. | 14998318 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.